IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.746
EU - Europa 24.567
AS - Asia 23.219
Continente sconosciuto - Info sul continente non disponibili 4.309
SA - Sud America 2.276
AF - Africa 419
OC - Oceania 87
Totale 80.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.595
GB - Regno Unito 8.282
CN - Cina 7.065
SG - Singapore 6.823
IT - Italia 4.261
RU - Federazione Russa 2.465
DE - Germania 2.320
SE - Svezia 1.911
HK - Hong Kong 1.892
VN - Vietnam 1.677
BD - Bangladesh 1.630
BR - Brasile 1.517
FR - Francia 1.278
TR - Turchia 1.016
IN - India 870
IE - Irlanda 825
KR - Corea 815
NL - Olanda 754
UA - Ucraina 733
CA - Canada 731
FI - Finlandia 614
EU - Europa 412
JP - Giappone 336
ID - Indonesia 290
CO - Colombia 283
ES - Italia 205
MX - Messico 205
PL - Polonia 190
AR - Argentina 181
GR - Grecia 111
IQ - Iraq 98
BE - Belgio 97
DK - Danimarca 93
CI - Costa d'Avorio 88
PH - Filippine 81
AT - Austria 72
ZA - Sudafrica 70
AU - Australia 69
EC - Ecuador 68
CL - Cile 67
CH - Svizzera 63
SA - Arabia Saudita 63
UZ - Uzbekistan 63
PK - Pakistan 60
VE - Venezuela 54
TW - Taiwan 53
IR - Iran 51
MY - Malesia 51
MA - Marocco 47
TH - Thailandia 42
EG - Egitto 39
RO - Romania 38
CR - Costa Rica 36
KE - Kenya 36
PT - Portogallo 35
PE - Perù 33
JM - Giamaica 30
NP - Nepal 29
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
HN - Honduras 26
DZ - Algeria 25
UY - Uruguay 25
IL - Israele 24
PY - Paraguay 23
BO - Bolivia 21
RS - Serbia 21
JO - Giordania 20
OM - Oman 20
LT - Lituania 19
NO - Norvegia 19
PR - Porto Rico 19
CZ - Repubblica Ceca 18
BY - Bielorussia 17
HR - Croazia 17
HU - Ungheria 17
AL - Albania 16
BG - Bulgaria 16
NZ - Nuova Zelanda 16
TT - Trinidad e Tobago 16
ET - Etiopia 14
LU - Lussemburgo 14
NI - Nicaragua 14
SV - El Salvador 14
AZ - Azerbaigian 13
KZ - Kazakistan 13
BB - Barbados 12
DO - Repubblica Dominicana 12
NG - Nigeria 12
KG - Kirghizistan 11
LB - Libano 11
PS - Palestinian Territory 11
GT - Guatemala 10
GE - Georgia 9
SY - Repubblica araba siriana 9
KW - Kuwait 8
SK - Slovacchia (Repubblica Slovacca) 8
UG - Uganda 7
AM - Armenia 6
EE - Estonia 6
Totale 76.575
Salva come PNG Salva come JPEG
Città #
Southend 7.635
Singapore 3.810
Ashburn 2.265
Hong Kong 1.768
San Jose 1.759
Chandler 1.754
Seattle 1.436
Beijing 1.334
Council Bluffs 1.252
Milan 1.130
Princeton 1.088
Santa Clara 1.014
Wilmington 858
Dallas 830
Dublin 808
Los Angeles 567
Ann Arbor 522
Redmond 518
Fairfield 474
Jacksonville 469
New York 469
Lauterbourg 463
Hangzhou 456
Bengaluru 428
Nanjing 428
Mountain View 426
Ho Chi Minh City 419
Des Moines 405
Moscow 385
Buffalo 374
Dearborn 367
Hanoi 358
Toronto 352
Frankfurt am Main 349
Hanover 349
Guangzhou 345
Sakarya 341
Boardman 319
Woodbridge 305
Shanghai 297
Houston 285
Rome 221
Serra 216
Bogotá 206
The Dalles 203
Redwood City 202
Somerville 195
Andover 191
Tokyo 186
Columbus 184
Hefei 178
Phoenix 175
Sunnyvale 169
Cangzhou 166
Jinan 166
Grafing 164
Tianjin 161
Dong Ket 160
Cambridge 151
Shenyang 147
Helsinki 144
São Paulo 132
Jakarta 126
Hebei 114
Shenzhen 113
Warsaw 113
Changsha 112
Munich 108
Eitensheim 106
Nanchang 102
Chicago 89
Zhengzhou 88
Berlin 87
Abidjan 86
Athens 84
Pisa 81
Seoul 80
Jiaxing 77
Da Nang 73
Brussels 68
San Diego 68
Turin 68
Fuzhou 67
Naples 65
London 62
Haiphong 60
Istanbul 59
Hamburg 56
Madrid 56
Montreal 54
Bitonto 53
Ottawa 53
Tashkent 53
Atlanta 51
Florence 50
Nuremberg 50
Wuhan 49
Kunming 48
Falls Church 47
Washington 47
Totale 45.751
Salva come PNG Salva come JPEG
Nome #
Management of Thrombotic Antiphospholipid Syndrome 785
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 773
The role of environmental estrogens and autoimmunity 643
The X chromosome and the sex ratio of autoimmunity 641
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 511
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) 488
Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases 487
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 450
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 376
Inflammatory response and the endothelium 372
X chromosome monosomy : a common mechanism for autoimmune diseases 371
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 371
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation 357
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 355
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 354
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 348
mTOR as a multifunctional therapeutic target in HIV infection 329
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis 329
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 327
Pidotimod : a reappraisal 309
Vitamin D and anti-phospholipid antibody syndrome : A comprehensive review 309
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons" 306
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome : evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients 302
X monosomy in female systemic lupus erythematosus 300
Anti-beta 2 glycoprotein I antibodies in centenarians 294
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 293
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 289
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1 : prevalence in systemic lupus erythematosus 284
Circulating stem cell factor in patients with chronic idiopathic urticaria 279
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 274
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 273
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 271
Anti-inflammatory and immunosuppressive drugs and reproduction 263
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 262
Complement activation in patients with COVID-19: a novel therapeutic target 262
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 261
Prolactin's role in the pathogenesis of the antiphospholipid syndrome 259
Primary biliary cirrhosis and Sjögren's syndrome : autoimmune epithelitis 258
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 258
Treatment of Thrombotic Antiphospholipid Syndrome : The Rationale of Current Management - An Insight into Future Approaches 256
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 248
Protective effect of a synthetic peptide mimicking the b2GPI PL-binding site on aPL-induced placental damage 247
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 247
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 246
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 244
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 243
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients 242
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 238
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study 234
Patients with antiphospholipid syndrome display endothelial perturbation 231
Systemic Lupus erythematosus complicated by thrombotic thrombocytopenic purpura 230
The geoepidemiology of autoimmune liver disease 230
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 228
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 225
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis : the interferon-inducible gene IFI16 223
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects 223
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 223
The chemokine scavenger receptor D6 protects the fetus from inflammation-induced abortion 219
L’evoluzione da sindrome da anticorpi antifosfolipidi primaria a lupus eritematoso sistemico : possono gli anticorpi anti-nucleosomi essere predittivi? 212
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 212
Lymphocyte markers and circulating immune complexes in primary glomerulonephritis 211
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome 211
Anti-DNA antibodies : a diagnostic and prognostic tool for systemic lupus erythematosus? 209
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 209
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 209
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in Chronic Fatigue Syndrome and Fibromyalgia but not in Depression: Preliminary report 208
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 208
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies 208
Antiphospholipid antibodies and ex-vivo endothelial perturbation 207
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 207
Increase of IgG-bearing peripheral blood lymphocytes and hypo IgG-globulinaemia in minimal change glomerulonephritis and focal glomerulosclerosis 207
Up-date on the antiphospholipid syndrome 205
Association between clinical features and inflammatory gene SNPs in APS 205
Anti-phospholipid induced murine fetal loss : novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss 205
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers 204
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 204
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block : an Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group" 204
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies 204
Endothelium as a target for antiphospholipid antibodies 203
Mechanisms of action of antiphospholipid antibodies 203
Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome 203
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 202
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 200
ANA screening : an old test with new recommendations 199
Anti-phospholipid antibody mediated fetal loss : still an open question from a pathogenic point of view 198
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays : an Italian multicentre study 198
Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies 198
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 196
Rheumatoid arthritis : a female challenge 196
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study 195
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 193
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 193
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 193
Sex and Management of Rheumatoid Arthritis 193
Assessment of musculoskeletal hand involvement in systemic sclerosis using ultrasonography and plain radiography 192
T cell defect in essential mixed cryoglobulinaemia 192
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination 191
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases 190
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 190
Prothrombotic biomarkers in patients with rheumatoid arthritis : the beneficial effect of IL-6 receptor blockade 190
Totale 27.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.089 0 0 123 194 323 256 456 288 539 478 397 1.035
2022/20236.277 881 586 530 773 637 1.323 112 423 576 73 251 112
2023/20243.665 118 314 204 238 968 267 99 177 79 215 445 541
2024/20259.441 402 1.099 228 856 774 391 339 1.066 533 756 907 2.090
2025/202622.389 1.773 1.026 2.400 1.575 2.152 1.578 2.638 1.448 2.484 1.523 1.985 1.807
2026/20273.441 1.454 1.731 256 0 0 0 0 0 0 0 0 0
Totale 80.623